David Su

Dr. David Su is an Assistant Professor in the Department of Surgery at Yale School of Medicine specializing in surgical oncology with expertise in melanoma, neuroendocrine tumors, and peritoneal surface malignancies. He holds an MD from University of California San Francisco (2020) and an AB in Chemical and Physical Biology from Harvard College (2014).

• Medical School: University of California San Francisco (2020)
• Undergraduate: Harvard College, Chemical and Physical Biology (2014)

Dr. Su's research program integrates artificial intelligence with spatial omics to analyze tumor microenvironments, with particular focus on immune checkpoint biomarkers in melanoma and molecular profiling of appendiceal cancers. His work bridges computational biology with clinical oncology, developing novel approaches for tumor-infiltrating immune cell scoring and spatial proteomic analysis. He has led national consensus efforts on peritoneal metastases management from neuroendocrine neoplasms.

His publication portfolio demonstrates a clear progression from HIV research to surgical oncology, with recent high-impact work in Nature Communications on spatial omics analysis. His research spans molecular diagnostics, tumor microenvironment characterization, and clinical translation of AI-driven approaches to cancer treatment.

Dr. Su actively contributes to surgical oncology through committee work including the Advanced Cancer Therapies Organizing Committee and communications committees for the Society of Asian Academic Surgeons and Society for Surgery of the Alimentary Tract.

His laboratory work focuses on digital spatial proteomic profiling and AI applications in surgical oncology, with recent recognition for research demonstrating AI outperforming humans in scoring melanoma tumor-infiltrating immune cells.